GeneDx believes in responsible testing that is based on established medical guidelines, and we aim to be completely transparent with our pricing so that patients, clinicians, and payers know the cost of the test.
Sequencing and deletion/duplication analysis of NF2 & SMARCB1
Turnaround time of 4 weeks
Pathogenic variants in SMARCB1 are also associated with rhabdoid tumor predisposition syndrome (RTPS1) and Coffin-Siris syndrome (CSS3), which are heterogeneous disorders. Comprehensive genetic testing for these disorders is available as a custom XomeDxSlice test